(Q83323654)
Statements
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome (English)
Christian Buske
Martin Dreyling
Joerg Hasford
Michael Unterhalt
Wolfgang Hiddemann